Monopar Therapeutics (MNPR) Stock Chart & Stock Price History $32.06 +0.22 (+0.69%) Closing price 04:00 PM EasternExtended Trading$32.06 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Monopar Therapeutics Stock Price Performance The Monopar Therapeutics (MNPR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 1,061.59%, with a year-to-date return of 45.73%. In the past month, the stock has decreased 29.10%, reflecting recent market activity. As of the latest close, Monopar Therapeutics traded at $31.84 with a market cap of $196.45 million and volume of 53,000 shares. Five years ago, the stock traded at a split-adjusted price of $28.45, representing a 12.69% increase over that period. At the time, it had a market cap of $66.24 million and a volume of 12,259 shares. Receive MNPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-10.22%1 Month Performance-29.10%3 Month Performance-9.54%Year-To-Date Performance+45.73%1 Year Performance+1,061.59%5 Year Performance+12.69% MNPR Stock Chart for Friday, August, 22, 2025 MNPR Chart by TradingView Monopar Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$33.00$31.84-3.52%$34.12$31.5053,000 shs$196.45 million08/20/2025$33.51$33.00-1.52%$34.33$31.9973,723 shs$203.61 million08/19/2025$34.26$33.51-2.19%$34.80$32.6040,492 shs$206.76 million08/18/2025$35.71$34.26-4.06%$37.56$34.1525,270 shs$211.38 million08/15/2025$35.86$35.71-0.42%$36.23$34.0317,461 shs$220.33 million08/14/2025$33.51$35.86+7.01%$36.51$32.5730,434 shs$219.46 million08/13/2025$35.90$33.51-6.66%$36.06$32.0126,833 shs$204.91 million08/12/2025$31.34$35.90+14.55%$35.90$30.9031,754 shs$219.71 million08/11/2025$34.65$31.34-9.55%$35.80$30.5130,675 shs$191.80 million08/08/2025$40.10$34.65-13.59%$41.49$34.6528,909 shs$212.06 million Get the Latest News and Ratings for MNPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$40.65$40.10-1.35%$41.70$39.5016,462 shs$245.21 million08/06/2025$40.45$40.65+0.49%$41.70$39.5020,337 shs$248.78 million08/05/2025$41.75$40.45-3.11%$42.50$39.2417,562 shs$247.55 million08/04/2025$40.69$41.75+2.61%$42.21$39.9228,749 shs$255.30 million08/01/2025$41.18$40.69-1.19%$41.60$39.6135,807 shs$248.82 million07/31/2025$42.66$41.18-3.47%$42.65$40.719,916 shs$252.02 million07/30/2025$43.03$42.66-0.86%$44.34$41.6713,086 shs$261.08 million07/29/2025$43.40$43.03-0.85%$44.36$41.508,963 shs$263.13 million07/28/2025$44.97$43.40-3.49%$44.58$43.0113,035 shs$265.61 million07/25/2025$46.82$44.97-3.95%$47.00$44.3710,251 shs$275.22 million07/24/2025$46.87$46.82-0.11%$47.52$45.2012,769 shs$286.54 million07/23/2025$45.22$46.87+3.65%$46.91$45.2014,761 shs$286.61 million07/22/2025$46.43$45.22-2.61%$45.54$44.2615,513 shs$276.75 million07/21/2025$46.48$46.43-0.11%$48.35$45.1129,618 shs$284.15 million Related Companies Mineralys Therapeutics Stock Price Chart Immunome Stock Price Chart Zymeworks Stock Price Chart atai Life Sciences Stock Price Chart Urogen Pharma Stock Price Chart Oculis Stock Price Chart Oric Pharmaceuticals Stock Price Chart Nuvation Bio Stock Price Chart Sionna Therapeutics Stock Price Chart Niagen Bioscience Stock Price Chart Receive MNPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MNPR) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access